Prilenia

HQ
Boston, MA
Total Offices: 2
41 Total Employees
Year Founded: 2018

Similar Companies Hiring

Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
16 Offices
121990 Employees
Software • Pharmaceutical • Manufacturing • Healthtech • Biotech • Analytics
4 Offices
50000 Employees
Machine Learning • Design • Biotech • Artificial Intelligence
Boston, MA
95 Employees

Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.

Our lead asset is Pridopidine, a first-in-class oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children.

Pridopidine is currently being evaluated for the treatment of Huntington’s disease in our global Phase 3 PROOF-HD trial, and for the treatment of ALS in the Phase 2/3 HEALEY platform trial.

The company is led by Dr. Michael Hayden, MD, PhD, the founder of five biotech companies and previous President of Global R&D and Chief Scientific Officer at Teva. Michael has directed the development of multiple innovative drug products, leading to 35 approvals between 2012-2018.

The Company is based in Naarden, the Netherlands, Herzliya, Israel and Boston, MA in the U.S.


Recently Posted Jobs at Prilenia

Prilenia Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
HQBoston, MA
Naarden, NL